Home / Stocks / AMP

Ameriprise Financial (AMP, Fund managers & custodians) Stock Valuation & Fair Value Favorable on our tests

Ameriprise Financial (AMP, Fund managers & custodians) trades at a current P/E of 11.2, about 15% below its historical normal valuation, with a forward growth estimate of 12.8% and a PEG of 0.87. Analysts' one-year estimates have been hit 64% of the time. Priced at its historical normal P/E of 13.1 on the same blended earnings, the 2026-10-09 close of $500.51 corresponds to about $589 a share. This is a valuation reference, not a price target.

No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation and forecast return, and for the top ratings, credit rating, growth and analyst accuracy.

Current P/E
11.2
Normal P/E
13.1
PEG
0.87
Fwd growth
12.8%
Div yield
1.4%
RSI (14)
39.9
Neutral
Technical context
  • Price $500.02 at the 2026-10-12 close, 1.7% below the 20-day average ($508.63) and 7.1% below the 50-day ($538.23).
  • RSI (14) at 39.9.
  • 52-week range $427.50 to $570.68: the price is 12.4% below the high and 17.0% above the low.

The Street vs SeerForecast

Wall Street's mean price target for AMP is $568.45 across 11 analysts, 13.7% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: favorable on our tests. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from mixed on our tests (2026-06-10) to favorable on our tests (2026-10-12). New rating rules took effect in the week of 2026-09-28, and this rating moved across that change, so part of the move may come from the new rules rather than the company.

Current P/E and rating by weekCurrent P/E moved from 11.0 to 11.2 between 2026-06-10 and 2026-10-09, against a normal P/E of 13.1, with 1 rating change over 38 recorded weeks.2026-06-10: P/E 11.0, Mixed on our tests, recalculated for the week of 2026-06-102026-06-12: P/E 11.0, Mixed on our tests, recalculated for the week of 2026-06-142026-06-16: P/E 11.0, Mixed on our tests, recalculated for the week of 2026-06-162026-06-18: P/E 11.0, Mixed on our tests, recalculated for the week of 2026-06-212026-07-02: P/E 11.5, Mixed on our tests, recalculated for the week of 2026-07-022026-07-06: P/E 11.7, Mixed on our tests, recalculated for the week of 2026-07-062026-07-09: P/E 11.7, Mixed on our tests, recalculated for the week of 2026-07-092026-07-10: P/E 12.0, Mixed on our tests, recalculated for the week of 2026-07-122026-07-13: P/E 12.0, Mixed on our tests, recalculated for the week of 2026-07-132026-07-14: P/E 12.0, Mixed on our tests, recalculated for the week of 2026-07-142026-07-20: P/E 12.4, Mixed on our tests, recalculated for the week of 2026-07-202026-07-22: P/E 12.4, Mixed on our tests, recalculated for the week of 2026-07-222026-07-24: P/E 12.3, Mixed on our tests, recalculated for the week of 2026-07-252026-07-27: P/E 12.3, Mixed on our tests, recalculated for the week of 2026-07-272026-07-31: P/E 12.6, Mixed on our tests, recalculated for the week of 2026-07-312026-07-31: P/E 12.6, Mixed on our tests, recorded live 2026-08-032026-08-07: P/E 12.8, Mixed on our tests, recalculated for the week of 2026-08-072026-08-07: P/E 12.7, Mixed on our tests, recorded live 2026-08-102026-08-14: P/E 13.1, Mixed on our tests, recalculated for the week of 2026-08-142026-08-14: P/E 13.0, Mixed on our tests, recorded live 2026-08-172026-08-21: P/E 12.5, Mixed on our tests, recalculated for the week of 2026-08-212026-08-21: P/E 12.7, Mixed on our tests, recorded live 2026-08-242026-08-27: P/E 12.7, Mixed on our tests, recalculated for the week of 2026-08-272026-08-28: P/E 12.6, Mixed on our tests, recalculated for the week of 2026-08-282026-08-28: P/E 12.7, Mixed on our tests, recalculated for the week of 2026-08-302026-08-28: P/E 12.7, Mixed on our tests, recorded live 2026-08-312026-09-04: P/E 12.7, Mixed on our tests, recalculated for the week of 2026-09-052026-09-04: P/E 12.7, Mixed on our tests, recorded live 2026-09-072026-09-11: P/E 12.6, Mixed on our tests, recalculated for the week of 2026-09-122026-09-11: P/E 12.6, Mixed on our tests, recorded live 2026-09-142026-09-18: P/E 12.3, Mixed on our tests, recalculated for the week of 2026-09-192026-09-18: P/E 12.3, Mixed on our tests, recorded live 2026-09-212026-09-25: P/E 11.1, Mixed on our tests, recalculated for the week of 2026-09-262026-09-25: P/E 11.1, Favorable on our tests, recorded live 2026-09-282026-10-02: P/E 11.0, Favorable on our tests, recalculated for the week of 2026-10-032026-10-02: P/E 11.0, Favorable on our tests, recorded live 2026-10-052026-10-09: P/E 11.2, Favorable on our tests, recalculated for the week of 2026-10-102026-10-09: P/E 11.2, Favorable on our tests, recorded live 2026-10-1211.012.013.0Jun 10Jul 10Aug 9Sep 9Oct 9Normal P/E 13.1
Favorable on our testsMixed on our tests

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekCurrent P/EPremium to normal P/ERating
2026-06-10P/E 11.0-16%Mixed on our tests (recalculated)
2026-08-14P/E 13.1-1%Mixed on our tests (recalculated)
2026-09-28P/E 11.1-16%Favorable on our tests (across a rating rules change)
2026-10-12P/E 11.2-15%Favorable on our tests ← now
Show all 38 weeks
WeekCurrent P/EPremium to normal P/ERating
2026-06-10P/E 11.0-16%Mixed on our tests (recalculated)
2026-06-14P/E 11.0-16%Mixed on our tests (recalculated)
2026-06-16P/E 11.0-16%Mixed on our tests (recalculated)
2026-06-21P/E 11.0-16%Mixed on our tests (recalculated)
2026-07-02P/E 11.5-13%Mixed on our tests (recalculated)
2026-07-06P/E 11.7-11%Mixed on our tests (recalculated)
2026-07-09P/E 11.7-11%Mixed on our tests (recalculated)
2026-07-12P/E 12.0-9%Mixed on our tests (recalculated)
2026-07-13P/E 12.0-9%Mixed on our tests (recalculated)
2026-07-14P/E 12.0-9%Mixed on our tests (recalculated)
2026-07-20P/E 12.4-5%Mixed on our tests (recalculated)
2026-07-22P/E 12.4-5%Mixed on our tests (recalculated)
2026-07-25P/E 12.3-7%Mixed on our tests (recalculated)
2026-07-27P/E 12.3-7%Mixed on our tests (recalculated)
2026-07-31P/E 12.6-4%Mixed on our tests (recalculated)
2026-08-03P/E 12.6-4%Mixed on our tests
2026-08-07P/E 12.8-2%Mixed on our tests (recalculated)
2026-08-10P/E 12.7-4%Mixed on our tests
2026-08-14P/E 13.1-1%Mixed on our tests (recalculated)
2026-08-17P/E 13.0-1%Mixed on our tests
2026-08-21P/E 12.5-5%Mixed on our tests (recalculated)
2026-08-24P/E 12.7-4%Mixed on our tests
2026-08-27P/E 12.7-4%Mixed on our tests (recalculated)
2026-08-28P/E 12.6-4%Mixed on our tests (recalculated)
2026-08-30P/E 12.7-3%Mixed on our tests (recalculated)
2026-08-31P/E 12.7-3%Mixed on our tests
2026-09-05P/E 12.7-3%Mixed on our tests (recalculated)
2026-09-07P/E 12.7-3%Mixed on our tests
2026-09-12P/E 12.6-4%Mixed on our tests (recalculated)
2026-09-14P/E 12.6-4%Mixed on our tests
2026-09-19P/E 12.3-7%Mixed on our tests (recalculated)
2026-09-21P/E 12.3-7%Mixed on our tests
2026-09-26P/E 11.1-16%Mixed on our tests (recalculated)
2026-09-28P/E 11.1-16%Favorable on our tests (across a rating rules change)
2026-10-03P/E 11.0-16%Favorable on our tests (recalculated)
2026-10-05P/E 11.0-16%Favorable on our tests
2026-10-10P/E 11.2-15%Favorable on our tests (recalculated)
2026-10-12P/E 11.2-15%Favorable on our tests ← now

Frequently asked questions

Is Ameriprise Financial stock overvalued?

At a current P/E of 11.2 versus its historical normal P/E of 13.1, Ameriprise Financial trades about 15% below its typical valuation, with a PEG of 0.87 on 12.8% forward growth. tickerseer currently rates it favorable on our tests.

What is Ameriprise Financial's fair value and PEG?

Ameriprise Financial trades at a current P/E of 11.2 against a historical normal P/E of 13.1, a PEG of 0.87, and a forward growth estimate of 12.8%. Priced at its historical normal P/E of 13.1 on the same blended earnings, the 2026-10-09 close of $500.51 corresponds to about $589 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Ameriprise Financial changed?

tickerseer's rating moved from mixed on our tests (2026-06-10) to favorable on our tests (2026-10-12). New rating rules took effect in the week of 2026-09-28, and this rating moved across that change, so part of the move may come from the new rules rather than the company.

What is the analyst price target for Ameriprise Financial?

The mean Wall Street price target for Ameriprise Financial is $568.45 across 11 analysts, 13.7% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Fund managers & custodians. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.